Recap: Ligand Pharmaceuticals Q4 Earnings


Ligand Pharmaceuticals LGND reported its Q4 earnings results on Thursday, February 17, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.


Ligand Pharmaceuticals beat estimated earnings by 31.39%, reporting an EPS of $1.8 versus an estimate of $1.37.

Revenue was up $2.48 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.54, which was followed by a 9.2% increase in the share price the next day.

Here's a look at Ligand Pharmaceuticals's past performance:


Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate 1.04 1.34 1.12 0.99
EPS Actual 1.58 1.63 1.41 1.62
Revenue Estimate 55.65M 70.41M 62.85M 54.09M
Revenue Actual 64.83M 84.67M 55.15M 69.99M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!